A pilot study of adherence to lenalidomide among older patients with multiple myeloma

被引：1
|
作者：
Silberstein, Alice E. [1 ]
Fiala, Mark A. [1 ,2 ]
Loh, Kah Poh [3 ]
Cordner, Theresa [1 ]
Mian, Hira [4 ]
Wildes, Tanya M. [5 ,6 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] St Louis Univ, Coll Publ Hlth & Social Justice, St Louis, MO USA
[3] Univ Rochester, James P Wilmot Canc Inst, Dept Med, Div Hematol Oncol,Med Ctr, Rochester, NY USA
[4] McMaster Univ, Hamilton, ON, Canada
[5] Univ Nebraska Med Ctr, Div Hematol Oncol, Nebraska Med, Omaha, NE USA
[6] 983332 Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
JOURNAL OF GERIATRIC ONCOLOGY | 2023年 / 14卷 / 07期
基金：
美国国家卫生研究院;
关键词：
MEDICATION ADHERENCE; COSTS;
D O I：
10.1016/j.jgo.2023.101560
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
    Mian, Hira
    Fiala, Mark
    Wildes, Tanya M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02): : 98 - +
  • [2] Adherence to Lenalidomide in Older Patients with Multiple Myeloma (MM): A SEER-Medicare Analysis
    Wildes, Tanya
    Fiala, Mark A.
    Vij, Ravi
    BLOOD, 2017, 130
  • [3] High Implementation Adherence to Lenalidomide in Patients with Multiple Myeloma
    Leader, Avi
    Magen, Hila
    Amitai, Irina
    Pironet, Antoine
    Tousset, Eric
    Rozental, Alon
    De Geest, Sabina
    Vaxman, Iuliana
    Raanani, Pia
    Nagler, Arnon
    BLOOD, 2022, 140 : 8068 - 8069
  • [4] Updated Perspectives on the Management of Multiple Myeloma in Older Patients: Focus on Lenalidomide
    Schoenbeck, Kelly L.
    Wildes, Tanya M.
    CLINICAL INTERVENTIONS IN AGING, 2020, 15 : 619 - 633
  • [5] Factors associated with non-adherence to lenalidomide in patients with multiple myeloma.
    Leng, Siyang
    Lentzsch, Suzanne
    Chen, Yizhen
    Accordino, Melissa Kate
    Wright, Jason Dennis
    Neugut, Alfred I.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] Subsequent Primary Malignancies Among Multiple Myeloma Patients Treated with or without Lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka S.
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert D.
    Sullivan, Daniel M.
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    BLOOD, 2014, 124 (21)
  • [7] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Li, Ang
    Wu, Qian
    Warnick, Greg
    Li, Shan
    Libby, Edward N.
    Garcia, David A.
    Lyman, Gary H.
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 121 - 126
  • [8] The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma
    Li, Ang
    Wu, Qian V.
    Warnick, Greg
    Libby, Edward N., III
    Garcia, David A.
    Lyman, Gary H.
    BLOOD, 2018, 132
  • [9] Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide
    Rollison, Dana E.
    Komrokji, Rami
    Lee, Ji-Hyun
    Hampras, Shalaka
    Fulp, William
    Fisher, Kate
    Baz, Rachid
    Nishihori, Taiga
    Xu, Qiang
    Olesnyckyj, Marta
    Kenvin, Laurie
    Knight, Robert
    Sullivan, Daniel
    Alsina, Melissa
    Dalton, William
    Shain, Kenneth H.
    LEUKEMIA & LYMPHOMA, 2017, 58 (03) : 560 - 568
  • [10] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
12345